ScholarLens Back to search
2005•The Chinese Journal of Modern Applied PharmacyRequires access

Clinical study of risperidone in the treatment of 189 cases patients with schizophrenia

Haidong Song

Open publisher page 0 citations

Abstract

OBJECTIVE To evaluate the efficacy and safety of risperidone in the treatment of schizophrenia.METHODS 189 schizophrenia were treated by risperidone (no control group),beginning dose of risperidone being 0.5mg/d then being added to therapying dose (2~5mg/d),all patients were evaluated 12 weeks.The efficacy and safety were evaluated by BPRS,CGI and TESS.RESULTS The efficacy of resperidone in the treatment of schizophrenia was 92.06%,treatment dosage was 3.35±1.68mg/d.Little side-effects were found.CONCLUSION The efficacy and safety of risperidone in the treatment of schizophrenia are satisfied.

About this research paper

What this paper is about

OBJECTIVE To evaluate the efficacy and safety of risperidone in the treatment of schizophrenia.METHODS 189 schizophrenia were treated by risperidone (no control group),beginning dose of risperidone being 0.5mg/d then being added to therapying dose (2~5mg/d),all patients were evaluated 12 weeks.The efficacy and safety were evaluated by BPRS,CGI and TESS.RESULTS The efficacy of resperidone in the treatment of schizophrenia was 92.06%,treatment dosage was 3.35±1.68mg/d.Little side-effects were found.CONCLUSION The efficacy and safety of risperidone in the treatment of schizophrenia are satisfied.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To evaluate the efficacy and safety of risperidone in the treatment of schizophrenia.METHODS 189 schizophrenia were treated by risperidone (no control group),beginning dose of risperidone being 0.5mg/d then being added to therapying dose (2~5mg/d),all patients were evaluated 12 weeks.The efficacy and safety were evaluated by BPRS,CGI and TESS.RESULTS The efficacy of resperidone in the treatment of schizophrenia was 92.06%,treatment dosage was 3.35±1.68mg/d.Little side-effects were found.CONCLUSION The efficacy and safety of risperidone in the treatment of schizophrenia are satisfied.

Key concepts: Risperidone, Schizophrenia (object-oriented programming), Clinical efficacy, Medicine, Side effect (computer science), Internal medicine, Psychiatry, Psychology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical study of risperidone in the treatment of 189 cases patients with schizophrenia — Research Paper | ScholarLens